Caplyta, the crown jewel of Johnson & Johnson's $14.6 billion buyout of Intra-Cellular Therapies, won the FDA’s blessing to ...
A new review of depression treatments suggests that the scientific evidence for many common strategies used when a first ...
The expanded indication for the oral atypical antipsychotic now includes adjunctive use with antidepressants in adults with major depressive disorder.
A diagnostic distinction for postpartum psychosis in the DSM will improve detection, treatment, and prevention, an expert ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback